Correct Answer: A. Systemic lupus erythematosus
The clinical tetrad of fever, oral ulcers, photosensitivity, and malar rash (butterfly distribution on cheeks and bridge of nose) is pathognomonic for systemic lupus erythematosus (SLE). The malar rash is the most distinctive cutaneous manifestation, occurring in ~40–60% of SLE patients, characteristically sparing the nasolabial folds. Photosensitivity (triggered by UVB/UVA exposure) is present in 40–70% of cases and often precedes or exacerbates systemic symptoms. Oral ulcers (painless, shallow, on hard palate or buccal mucosa) occur in 20–30% and are part of the mucocutaneous involvement. Fever reflects systemic inflammation and is a cardinal feature of active SLE. The combination of these four findings, especially with the characteristic facial distribution, meets ACR/EULAR criteria for SLE diagnosis. In the Indian population, SLE predominantly affects women of reproductive age (female:male ratio 9:1), and photosensitivity is particularly common in darker-skinned populations due to increased UV exposure and melanin reactivity. The diagnosis is confirmed by positive ANA (>95% sensitive), anti-dsDNA, and anti-Smith antibodies. Early recognition and immunosuppressive therapy (corticosteroids, hydroxychloroquine, azathioprine per AIIMS/ICMR guidelines) prevent organ damage.
Why the other options are wrong
B. Rosacea — Rosacea presents with persistent facial erythema, telangiectasia, and acneiform papules on the central face, but lacks systemic features like fever, oral ulcers, and photosensitivity-triggered exacerbations. Rosacea is a chronic vascular disorder without constitutional symptoms or autoimmune serology. The absence of fever and oral ulcers rules this out immediately. C. Melasma — Melasma is a benign hyperpigmentary disorder presenting as symmetric brown patches on the face (cheeks, forehead, upper lip), common in Indian women due to genetic predisposition and UV exposure. It is purely cosmetic with no systemic symptoms, fever, oral ulcers, or photosensitivity-triggered flares. The clinical presentation of systemic illness excludes this diagnosis entirely. D. Dermatomyositis — Dermatomyositis presents with heliotrope rash (violaceous edema of eyelids), Gottron papules (over knuckles), and proximal muscle weakness—not a malar rash. While photosensitivity and systemic symptoms occur, the absence of oral ulcers and the different facial rash distribution (periorbital vs. malar) distinguish it from SLE. Muscle involvement would be a prominent feature.
High-Yield Facts
- Malar rash in SLE is butterfly-shaped, spares nasolabial folds, and occurs in 40–60% of patients—most specific cutaneous sign.
- Photosensitivity in SLE (40–70% prevalence) is triggered by UVB/UVA and often precedes systemic flares; hydroxychloroquine provides photoprotection.
- Oral ulcers in SLE are painless, shallow, on hard palate/buccal mucosa, and occur in 20–30%—part of mucocutaneous criteria.
- ANA positivity (>95% sensitive) is the screening test; anti-dsDNA and anti-Smith are highly specific for SLE diagnosis.
- Female:male ratio 9:1 in SLE; peak onset 15–45 years; Indian women show higher photosensitivity due to melanin reactivity.
- ACR/EULAR 2019 criteria require ≥10 points from clinical + immunological domains; malar rash + photosensitivity + oral ulcers + fever = high probability.
Mnemonics
SOAP BRAIN MD (SLE Criteria Memory) Serositis, Oral ulcers, ANA+, Photosensitivity | Blood cytopenias, Renal, AntidsDNA/Smith, Immunologic, Neurologic | Malar rash, Discoid rash. Use this to recall the 11 ACR criteria when screening for SLE. Malar Rash = Butterfly Spares Nasolabial (BSLN) The malar rash of SLE is Butterfly-shaped and Spares the nasolabial folds—this distinguishes it from other facial rashes. Remember: if the rash crosses the nasolabial fold, think rosacea or seborrheic dermatitis instead.
NBE Trap
NBE may pair photosensitivity with dermatomyositis (which does have photosensitivity) to trap students who forget that dermatomyositis lacks malar rash and oral ulcers. The specific combination of malar rash + oral ulcers + photosensitivity + fever is the discriminator for SLE.
Clinical Pearl
In Indian clinical practice, SLE often presents insidiously with photosensitivity-triggered flares during summer months; early recognition of the malar rash + oral ulcers triad and prompt ANA testing prevent progression to lupus nephritis (most common cause of morbidity in Indian SLE cohorts). Hydroxychloroquine 200–400 mg daily is the cornerstone of therapy per AIIMS guidelines.
_Reference: Robbins Ch. 6 (Systemic Lupus Erythematosus); Harrison Ch. 312 (SLE); Park's Textbook of Preventive & Social Medicine (epidemiology in India)_